Panmure Gordon (UK) Limited, an exempt principal trader, has disclosed its dealings in the securities of Allergy Therapeutics plc. On August 7, 2023, Panmure Gordon purchased 9,000 0.1p ordinary shares at a price of 0.0346 per unit. Additionally, the company sold 379,733 0.1p ordinary shares at a price of 0.036 per unit. No cash-settled derivative transactions or stock-settled derivative transactions were reported. There were no indemnity or option arrangements, agreements, or understandings related to relevant securities. The disclosure was made in accordance with Rule 8 of the Takeover Code.